Insulin resistance, postprandial GLP-1 and adaptive immunity are the main predictors of NAFLD in a homogeneous population at high cardiovascular risk
- PMID: 27134062
- DOI: 10.1016/j.numecd.2016.01.011
Insulin resistance, postprandial GLP-1 and adaptive immunity are the main predictors of NAFLD in a homogeneous population at high cardiovascular risk
Abstract
Background and aims: The role of the different factors associated with fatty liver is still poorly defined. We evaluated the relationships between liver fat content (LF) and metabolic, inflammatory and nutritional factors in a homogeneous cohort of individuals at high cardio-metabolic risk.
Methods and results: In 70 individuals with high waist circumference and at least one more criterion for metabolic syndrome enrolled in a nutritional intervention study, LF was evaluated at baseline by hepatic/renal echo intensity ratio (H/R), together with dietary habits (7-day dietary record), insulin sensitivity and β-cell function (fasting and OGTT-derived indices), fasting and postprandial plasma GLP-1 and lipoproteins, and plasma inflammatory markers. H/R correlated positively with fasting and OGTT plasma glucose and insulin concentrations, HOMA-IR and β-cell function, and IL-4, IL-17, IFN-γ, TNF-α, FGF and GCSF plasma concentrations (p < 0.05 for all), and negatively with insulin sensitivity (OGIS), dietary, polyphenols and fiber (p < 0.05 for all). By multiple stepwise regression analysis, the best predictors of H/R were OGIS (β = -0.352 p = 0.001), postprandial GLP-1 (β = -0.344; p = 0.001), HDL-cholesterol (β = -0.323; p = 0.002) and IFN-γ (β = 0.205; p = 0.036).
Conclusion: A comprehensive evaluation of factors associated with liver fat, in a homogeneous population at high cardio-metabolic risk, indicated a pathogenic combination of the same pathways underlying the atherosclerotic process, namely whole body insulin sensitivity and inflammation. The higher predictive value of postprandial variables suggests that liver fat is essentially a postprandial phenomenon, with a relevant role possibly played by GLP-1.
Registration number for clinical trials: NCT01154478.
Keywords: GLP-1; HDL; IFN-g; Inflammation; Insulin resistance; NAFLD.
Copyright © 2016 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
Comment in
-
Reply from the authors to "Comments on 'Insulin resistance, postprandial GLP-1 and adaptive immunity are the main predictors of NAFLD in a homogeneous population at high cardiovascular risk'".Nutr Metab Cardiovasc Dis. 2017 Jan;27(1):91-92. doi: 10.1016/j.numecd.2016.09.007. Epub 2016 Sep 21. Nutr Metab Cardiovasc Dis. 2017. PMID: 27914695 No abstract available.
-
Comments on "Insulin resistance, postprandial GLP-1 and adaptive immunity are the main predictors of NAFLD in a homogeneous population at high cardiovascular risk".Nutr Metab Cardiovasc Dis. 2017 Jan;27(1):90-91. doi: 10.1016/j.numecd.2016.08.007. Nutr Metab Cardiovasc Dis. 2017. PMID: 28061944 No abstract available.
Similar articles
-
[Incretins-adipocytokines interactions in type 2 diabetic subjects with or without non-alcoholic fatty liver disease: interest of GLP-1 (glucagon-like peptide-1) as a modulating biomarker].Ann Biol Clin (Paris). 2019 Jun 1;77(3):261-271. doi: 10.1684/abc.2019.1436. Ann Biol Clin (Paris). 2019. PMID: 30998190 French.
-
Polyphenol-rich diets improve glucose metabolism in people at high cardiometabolic risk: a controlled randomised intervention trial.Diabetologia. 2015 Jul;58(7):1551-60. doi: 10.1007/s00125-015-3592-x. Epub 2015 Apr 24. Diabetologia. 2015. PMID: 25906754 Clinical Trial.
-
Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.World J Gastroenterol. 2015 Apr 21;21(15):4688-95. doi: 10.3748/wjg.v21.i15.4688. World J Gastroenterol. 2015. PMID: 25914480 Free PMC article.
-
Metabolic Syndrome-Role of Dietary Fat Type and Quantity.Nutrients. 2019 Jun 26;11(7):1438. doi: 10.3390/nu11071438. Nutrients. 2019. PMID: 31247933 Free PMC article. Review.
-
Glucagon-like peptide-1 as a key regulator of lipid and lipoprotein metabolism in fasting and postprandial states.Cardiovasc Hematol Disord Drug Targets. 2014;14(2):126-36. doi: 10.2174/1871529x14666140505125300. Cardiovasc Hematol Disord Drug Targets. 2014. PMID: 24801723 Review.
Cited by
-
Wholegrain Intake and Risk of Type 2 Diabetes: Evidence from Epidemiological and Intervention Studies.Nutrients. 2018 Sep 12;10(9):1288. doi: 10.3390/nu10091288. Nutrients. 2018. PMID: 30213062 Free PMC article. Review.
-
Dietary Fibre as a Unifying Remedy for the Whole Spectrum of Obesity-Associated Cardiovascular Risk.Nutrients. 2018 Jul 21;10(7):943. doi: 10.3390/nu10070943. Nutrients. 2018. PMID: 30037123 Free PMC article. Review.
-
Human Postprandial Nutrient Metabolism and Low-Grade Inflammation: A Narrative Review.Nutrients. 2019 Dec 7;11(12):3000. doi: 10.3390/nu11123000. Nutrients. 2019. PMID: 31817857 Free PMC article. Review.
-
Reduction of De Novo Lipogenesis Mediates Beneficial Effects of Isoenergetic Diets on Fatty Liver: Mechanistic Insights from the MEDEA Randomized Clinical Trial.Nutrients. 2022 May 23;14(10):2178. doi: 10.3390/nu14102178. Nutrients. 2022. PMID: 35631319 Free PMC article. Clinical Trial.
-
The LIPL study: Postprandial lipid profile, inflammation, and platelet activity in patients with chronic coronary syndrome.Atheroscler Plus. 2023 Sep 21;54:14-21. doi: 10.1016/j.athplu.2023.09.002. eCollection 2023 Dec. Atheroscler Plus. 2023. PMID: 37811126 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
